Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Histotripsy focal ablation of implanted prostate tumor in an ACE-1 canine cancer model.

Schade GR, Keller J, Ives K, Cheng X, Rosol TJ, Keller E, Roberts WW.

J Urol. 2012 Nov;188(5):1957-64. doi: 10.1016/j.juro.2012.07.006.

2.

Histotripsy: minimally invasive technology for prostatic tissue ablation in an in vivo canine model.

Lake AM, Hall TL, Kieran K, Fowlkes JB, Cain CA, Roberts WW.

Urology. 2008 Sep;72(3):682-6. doi: 10.1016/j.urology.2008.01.037.

PMID:
18342918
3.

Histotripsy of the Prostate in a Canine Model: Characterization of Post-Therapy Inflammation and Fibrosis.

Darnell SE, Hall TL, Tomlins SA, Cheng X, Ives KA, Roberts WW.

J Endourol. 2015 Jul;29(7):810-5. doi: 10.1089/end.2014.0585.

4.

Prostate histotripsy in an anticoagulated model.

Wheat JC, Hall TL, Hempel CR, Cain CA, Xu Z, Roberts WW.

Urology. 2010 Jan;75(1):207-11. doi: 10.1016/j.urology.2009.09.021.

5.

Histotripsy fractionation of prostate tissue: local effects and systemic response in a canine model.

Hempel CR, Hall TL, Cain CA, Fowlkes JB, Xu Z, Roberts WW.

J Urol. 2011 Apr;185(4):1484-9. doi: 10.1016/j.juro.2010.11.044.

6.

Histotripsy of the prostate using a commercial system in a canine model.

Roberts WW, Teofilovic D, Jahnke RC, Patri J, Risdahl JM, Bertolina JA.

J Urol. 2014 Mar;191(3):860-5. doi: 10.1016/j.juro.2013.08.077.

PMID:
24012583
7.

Urethral-sparing histotripsy of the prostate in a canine model.

Schade GR, Hall TL, Roberts WW.

Urology. 2012 Sep;80(3):730-5. doi: 10.1016/j.urology.2012.05.027.

8.

Endoscopic assessment and prediction of prostate urethral disintegration after histotripsy treatment in a canine model.

Schade GR, Styn NR, Hall TL, Roberts WW.

J Endourol. 2012 Feb;26(2):183-9. doi: 10.1089/end.2011.0349.

9.

Histotripsy effects on the bladder trigone: functional and histologic consequences in the canine model.

Allam CL, Wilkinson JE, Cheng X, Ives KA, Hall TL, Roberts WW.

J Endourol. 2013 Oct;27(10):1267-71. doi: 10.1089/end.2013.0234.

10.

Histotripsy of the prostate: dose effects in a chronic canine model.

Hall TL, Hempel CR, Wojno K, Xu Z, Cain CA, Roberts WW.

Urology. 2009 Oct;74(4):932-7. doi: 10.1016/j.urology.2009.03.049.

11.

Histotripsy of VX-2 tumor implanted in a renal rabbit model.

Styn NR, Wheat JC, Hall TL, Roberts WW.

J Endourol. 2010 Jul;24(7):1145-50. doi: 10.1089/end.2010.0123.

12.

Histotripsy homogenization of the prostate: thresholds for cavitation damage of periprostatic structures.

Styn N, Hall TL, Fowlkes JB, Cain CA, Roberts WW.

J Endourol. 2011 Sep;25(9):1531-5. doi: 10.1089/end.2010.0648.

13.

A novel canine model for prostate cancer.

Keller JM, Schade GR, Ives K, Cheng X, Rosol TJ, Piert M, Siddiqui J, Roberts WW, Keller ET.

Prostate. 2013 Jun;73(9):952-9. doi: 10.1002/pros.22642. Erratum in: Prostate. 2014 Sep;74(12):1249. Dosage error in article text.

14.

Nanodroplet-mediated histotripsy for image-guided targeted ultrasound cell ablation.

Vlaisavljevich E, Durmaz YY, Maxwell A, Elsayed M, Xu Z.

Theranostics. 2013 Oct 20;3(11):851-64. doi: 10.7150/thno.6717.

15.

Prostate histotripsy: evaluation of prostatic urethral treatment parameters in a canine model.

Schade GR, Styn NR, Ives KA, Hall TL, Roberts WW.

BJU Int. 2014 Mar;113(3):498-503. doi: 10.1111/bju.12333.

16.

Development and translation of histotripsy: current status and future directions.

Roberts WW.

Curr Opin Urol. 2014 Jan;24(1):104-10. doi: 10.1097/MOU.0000000000000001. Review.

17.

Histotripsy of renal implanted VX-2 tumor in a rabbit model: investigation of metastases.

Styn NR, Hall TL, Fowlkes JB, Cain CA, Roberts WW.

Urology. 2012 Sep;80(3):724-9. doi: 10.1016/j.urology.2012.06.020.

PMID:
22925247
18.

Percutaneous ablation of canine prostate using transrectal ultrasound guidance. Absolute ethanol and Nd:YAG laser.

Littrup PJ, Lee F, Borlaza GS, Sacknoff EJ, Torp-Pedersen S, Gray JM.

Invest Radiol. 1988 Oct;23(10):734-9.

PMID:
3056869
19.

Bilateral focal ablation of prostate tissue using low-energy direct current (LEDC): a preclinical canine study.

Tsivian M, Polascik TJ.

BJU Int. 2013 Aug;112(4):526-30. doi: 10.1111/bju.12227.

20.

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.

Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L; International Task Force on Prostate Cancer and the Focal Lesion Paradigm..

J Urol. 2007 Dec;178(6):2260-7. Review.

PMID:
17936815

Supplemental Content

Support Center